Edesa Biotech (EDSA) Preferred Shares (2018 - 2026)
Edesa Biotech (EDSA) posted Preferred Shares of $8.2 million for Q4 2025, up 647.9% sequentially from $1.1 million in Q3 2025, and up 732.48% YoY from $981174.0 in Q4 2024.
Edesa Biotech (EDSA) Preferred Shares (2018 - 2026) Analysis & Trends
Edesa Biotech has reported Preferred Shares for 4 years, with the latest figure at $8.2 million in Q4 2025.
- Quarterly Preferred Shares rose 732.48% year-over-year to $8.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $8.2 million (up 732.48% YoY) and the FY2025 annual result came in at $1.1 million, changed N/A from the prior year.
- Preferred Shares advanced to $8.2 million in Q4 2025 per EDSA's latest filing, from $1.1 million in the prior quarter.
- Over five years, Preferred Shares peaked at $8.2 million in Q2 2025 and troughed at $981174.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Edesa Biotech | 40.44 Mn | 40.44 Mn | - | 7.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7.21 Mn |
| Dec 31, 2025 | 8.17 Mn |
| Sep 30, 2025 | 1.09 Mn |
| Jun 30, 2025 | 8.17 Mn |
| Mar 31, 2025 | 1.02 Mn |
| Dec 31, 2024 | 981,174.00 |
| Dec 31, 2020 | 1.37 Mn |
| Sep 30, 2020 | 2.48 Mn |
| Jun 30, 2020 | 2.46 Mn |
| Dec 31, 2018 | 6.06 Mn |